Bladder Control Medications: Classes, Mechanisms & Selection Guide

Pharmacotherapy targets specific bladder dysfunction types. Selection depends on diagnosis, comorbidities, and side-effect profile.

Overactive Bladder (OAB) / Urgency Incontinence

Stress Urinary Incontinence (SUI)

  • No FDA-approved drugs in US. Duloxetine (SNRI) used off-label/outside US – increases urethral sphincter tone via Onuf's nucleus.

Outlet Obstruction / BPH (Men)

  • Alpha-blockers: Tamsulosin, Alfuzosin, Silodosin – relax prostate/bladder neck smooth muscle.
  • 5-ARIs: Finasteride, Dutasteride – shrink prostate over months.
  • Combination: For larger prostates.

Other Agents

  • Antispasmodics: Hyoscyamine, Dicyclomine – visceral analgesia for bladder pain/spasm.
  • OnabotulinumtoxinA: Intradetrusor injection for refractory OAB (100U).
  • Vaginal estrogen: Genitourinary syndrome of menopause – improves urethral mucosa, urgency.

Selection Considerations

  • Beers Criteria: avoid strong anticholinergics in elderly (cognitive risk).
  • Narrow-angle glaucoma contraindicates anticholinergics.
  • Monitor BP with mirabegron.
  • Start low, titrate; assess at 4–8 weeks.

Urine Therapy - Related Articles

Health Sciences © https://www.222health.com

ClassExamplesMechanismKey Side Effects
AnticholinergicsOxybutynin, Tolterodine, Solifenacin, Darifenacin, FesoterodineBlock M3 muscarinic receptors → reduce detrusor contractionsDry mouth, constipation, blurred vision, cognitive risk (elderly), urinary retention
Beta-3 AgonistsMirabegron, VibegronRelax detrusor via β3-adrenoceptor → increase bladder capacityHTN, UTI, headache; minimal anticholinergic effects
CombinationMirabegron + solifenacinSynergisticCombined profiles